期刊文献+

非抗病毒治疗相关的慢性乙型肝炎患者YMDD变异研究 被引量:4

Study of YMDD mutations in the patients of chronic hepatitis B untreated with Killing virus's medicines
下载PDF
导出
摘要 目的 :了解未经抗病毒治疗的慢性乙型肝炎患者乙型肝炎病毒基因 YMDD变异及其与前 C区变异、HBV基因型的相关性 ,HBV DNA水平与变异发生的关系。方法 :从 1 2 6例均未接受拉米夫定治疗和近一年内未经任何抗病毒治疗的慢性乙肝患者随机抽取 2 5例为研究对象。血清 YMDD变异检测运用微板核酸杂交 -核酸定量法 ,HBV基因型采用 PCR微板核酸杂交 - EL ISA技术 ,HBV DNA定量采用荧光定量 PCR分析系统 ,HBV- M采用 EL ISA法。结果 :7例存在 YMDD变异 ,变异者 HBe Ag全部阳性 ,不同的 HBV基因型形式存在不同的 YMDD变异率 ,HBV DNA水平与 YMDD变异的发生不呈正相关结论 :HBV存在 YMDD野生变异株 ,并非完全由抗病毒治疗引起 ,变异株与前 C区变异和 HBV基因型的相关性以及 Objective:To explore the relation between the YMDD mutations and it's pre C domain mutation and genotypes of hepatitis B virus(HBV),also to investigate the relationship of level of HBV DNA and possibility of mutations in the patients of chronic hepatitis B untreated with Killing virus's medicine Methods:The twenty five cases optional by 126 patients of chronic hepatitis B untreated with lamivudine and Killing virus's medicine one year were detected.The YMDD mutations of serum was detected by microplate sandwich hybridization nucleic acid ration,genotypes of HBV was detected by PCR microplate sandwich hybridization ELISA,HBV DNA quantifying assessment was detected by fluorescence ration PCR analysis,hepatitis B virus markers were detected by ELISA Results:Mutations were detected in seven of 25 sample,all mutation's HBeAg were positive. Mutations rate is not same in each genotype Conclusion:There are some YMDD mutations in the patients of chronic hepatitis B untreated with Killing virus's medicine.It need to farther research about the relationship of YMDD mutations and pre C domain mutation and genotypes of HBV
出处 《广西医学》 CAS 2003年第12期2411-2413,共3页 Guangxi Medical Journal
基金 广西自然科学基金项目 桂科计字 (2 0 0 2 )第 4 9号
关键词 慢性乙型肝炎 YMDD变异 乙肝病毒 前C区变异 HBV基因型 相关性 Hepatitis B virus Chronic hepatitis YMDD mutation
  • 相关文献

参考文献7

二级参考文献10

共引文献413

同被引文献26

  • 1吴晓荫,张洋,张国虎.乙型肝炎病毒基因型与干扰素及拉米夫定疗效的关系[J].中国临床保健杂志,2004,7(4):278-280. 被引量:11
  • 2覃亚勤,赵登蕴,覃后继,李朝敢,黄重敏.125例广西壮族慢性肝病HBV YMDD自然变异研究[J].中国医师杂志,2005,7(11):1551-1552. 被引量:3
  • 3KobayashiS, Ide T,Sata M . Detection of YMDD motifmutations in some lain ivudine untrated asymptomatic hepatitis B virus carriers[J] . J Hepatol, 2001,34(4) : 584-586.
  • 4Suzuki F,Tsubota A,Arase Y,etal Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hcpatitis B virus infcction in Japan[J]. Intervirology,2003 46(3) : 182-189.
  • 5COUROUCE-PAUTY A M,PLANCON A,SOULIER J P.Distribution of HBsAg subtypes in the world[J].Vox Sang,1983,44(4):197-211.
  • 6LIAW Y F.Therapy of chronic hepatitis B:current challenges and opportunities[J].J Viral Hepat,2002,9(6):393-399.
  • 7BUTI M,SANCHEZ F,COTRINA M,et al.Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivdine therapy in patients with chronic hepatitis B[J].J Infect Dis,2001,183(8):1277-1280.
  • 8ONO NITA S K,KATO N,SHIRATORI Y,et al.YMDD motif in hepatitis B vifus DNA polymeras influeces on replication and lamivudine resistance:a study by in vitro full length viral DNA transfection[J].Hepatology,1999,29(1):939-942.
  • 9LAI C,CHIN R N,LEUNG N W Y,et al.one year trial of lamivudine for chronic hepatitis B[J].N Eng J Med,1998,339:61-64.
  • 10CHO S W,HAHM K B,KIM J H.Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy[J].Hepatology,2000,32:1163-1166.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部